Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Familial pterygium of the conjunctiva is a rare form of pterygium, which develops in early adulthood, characterized by a wing-like bulbar thickening of the conjunctiva in the interpalpebral fissure area that can be cured by surgical excision.
Features include: Abnormal conjunctiva morphology and Pterygium.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Eyes | 1 | Abnormal conjunctiva morphology |
Biomarker and diagnostic research for familial pterygium of the conjunctiva has been reported in the published literature.
10 clinical trials registered, 3 recruiting. Interventions under study include procedural interventions, drug therapy, medical devices, and biologic therapy. Pipeline includes 1 PHASE4, 1 PHASE3, 1 PHASE1. Research is sponsored by a mix of industry and academic institutions.
NCT ID | Title | Phase | Sponsor | Status |
|---|---|---|---|---|
[NCT03321201](https://clinicaltrials.gov/study/NCT03321201) |
Data assembled from 6 of 12 sources · Last updated Sep 20, 2026, 11:34 PM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Cauterization Versus fibrin Glue for Conjunctival Autografting in Primary Pterygium Surgery |
NA |
University of Split, School of Medicine |
RECRUITING |
[NCT07343011](https://clinicaltrials.gov/study/NCT07343011) | Conjunctival Transpositional Surgery for Primary Pterygium | NA | Zahedan University of Medical Sciences | RECRUITING |
[NCT07634913](https://clinicaltrials.gov/study/NCT07634913) | Development of a Mobile Terminal-Based Intelligent Detection System for Multiple Anterior Segment Diseases of the Eye | — | Zhongshan Ophthalmic Center, Sun Yat-sen University | RECRUITING |
165 publications have been identified in PubMed for familial pterygium of the conjunctiva. Research spans Basic Science / Preclinical (29%), Clinical Trial Publication (23%), and Review / Meta-Analysis (18%).
Research Type | Count | % of Total |
|---|---|---|
Laboratory research | 48 | 29% |
Clinical study results | 38 | 23% |
Research summaries | 30 | 18% |
Disease patterns and progression | 20 | 12% |
Patient case studies | 12 | 7% |
Testing and diagnosis research | 8 | 5% |
New treatment approaches | 6 | 4% |
Other research | 3 | 2% |
Shen J (2026). [PMID: 42249342](https://pubmed.ncbi.nlm.nih.gov/42249342/). *BMC Ophthalmol*. [Basic Science / Preclinical]
Quintana-Beltrán Y (2026). [PMID: 41786132](https://pubmed.ncbi.nlm.nih.gov/41786132/). *Arch Soc Esp Oftalmol (Engl Ed)*. [Clinical Trial Publication]
Pardo-Bayona M (2026). [PMID: 42143290](https://pubmed.ncbi.nlm.nih.gov/42143290/). *BMC Ophthalmol*. [Epidemiology / Natural History]
Siddiqui F (2026). [PMID: 42146948](https://pubmed.ncbi.nlm.nih.gov/42146948/). *Rom J Ophthalmol*. [Epidemiology / Natural History]
Sakata R (2026). [PMID: 41748055](https://pubmed.ncbi.nlm.nih.gov/41748055/). *Am J Ophthalmol*. [Diagnostic / Biomarker]
Saout Arrih B (2026). [PMID: 42130568](https://pubmed.ncbi.nlm.nih.gov/42130568/). *Int J Surg Case Rep*. [Case Report / Case Series]
Chen HC (2026). [PMID: 41760258](https://pubmed.ncbi.nlm.nih.gov/41760258/). *Anticancer Res*. [Gene Therapy / Novel Therapeutics]
Peng W (2026). [PMID: 42257741](https://pubmed.ncbi.nlm.nih.gov/42257741/). *Int Ophthalmol*. [Clinical Trial Publication]
Zhu X (2026). [PMID: 41948580](https://pubmed.ncbi.nlm.nih.gov/41948580/). *Front Med (Lausanne)*. [Epidemiology / Natural History]
Chen HC (2026). [PMID: 41771571](https://pubmed.ncbi.nlm.nih.gov/41771571/). *Cancer Genomics Proteomics*. [Gene Therapy / Novel Therapeutics]